CLEVELAND, June 27, 2018 (GLOBE NEWSWIRE) — Innovest Global Inc. (OTC Markets:IVST) (the “Company” or “Innovest”), a diversified holding company with operations in commercial and industrial products and services, and health services, today disclosed the name of Byram Healthcare as the previously announced award of a call center contract with a division of Fortune 500 global healthcare solutions company, Owens & Minor, Inc.
The initial contract award was announced on May 21, 2018. Training of the initial twelve person team Innovest is deploying for Byram, was completed this week.
Byram Healthcare is well-positioned for continued growth and ran a competitive bid process to find a call center partner that would assist and support its growth. The new contract builds on an existing relationship and Byram Healthcare believes that the Innovest Call Center will generate additional sales for Byram. The new contract is designed to accommodate Byram as it grows its customer base.
“The Innovest team is highly professional, does an incredible job for us at the right price, and takes our business as seriously as we do,” said Perry Bernocchi, Chief Executive Officer of Byram Healthcare. “After reviewing all proposals and interviewing all the companies that submitted bids, we found them to be the ideal partner to speak with our customers and service their needs. To our customers, they are part of the Byram team, and they’ve proven we can rely on them to be a proud part of our family.”
Dan Martin, Innovest Chief Executive Officer, commented, “This is the single largest contract for Innovest, since launching our Commercial & Industrial Division. It’s a great validation of our call center to win a major bid from a Fortune 500 company. We look forward to assisting in the growth of Byram Healthcare.”
Byram has been a national leader in the delivery of disposable medical supplies since 1968. Byram provides quality supplies, services and support, specializing in diabetes supplies, ostomy supplies, wound care supplies, urology supplies, incontinence supplies and enteral nutrition products. In 2017, Byram was acquired by Owens & Minor, a global healthcare solutions company, to expand the organization’s ability to serve the continuum of care into the patient’s home. Byram Healthcare, an Owens & Minor company, is more prepared than ever to tackle the challenging, changing healthcare landscape. Owens & Minor is a Fortune 500 company with over $2 billion in annual revenue.
Innovest’s Call Center is HIPAA and PCI Compliant, and has many internal controls, policies, and procedures that add to client confidence.
About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy and health services. Innovest Global utilizes novel technology and marketing to efficiently acquire customers. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and have announced a Biotechnology & Health Sciences Division that will launch in 2018.
For more information, please visit: http://www.innovestglobal.com
You can also follow on social media:
Innovest Twitter: https://twitter.com/InnovestGlobal
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company’s control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company’s filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.
All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated two thousand five hundred dollars cash and fifty thousand restricted shares for the creation and dissemination of this content.
This material does not represent an investment solicitation. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.
The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: https://spotlightgrowth.com//disclosures/